Antibiotic-Free Selection in Biotherapeutics: Now and Forever
Open accessThe DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
The continuously improving sophistication of molecular engineering techniques gives access to novel classes of bio-therapeutics and new challenges for their production in full respect of the strengthening regulations. Among these biologic agents are DNA based vaccines or gene therapy products and to a lesser extent genetically engineered live vaccines or delivery vehicles. The use of antibiotic-based selection, frequently associated with genetic manipulation of microorganism is currently undergoing a profound metamorphosis with the implementation and diversification of alternative selection means. This short review will present examples of alternatives to antibiotic selection and their context of application to highlight their ineluctable invasion of the bio-therapeutic world.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The global health agencies (FDA, EMA, WHO) also discourage the use of β-lactams (i.e., ampicillin, penicillin) and streptomycin resistance genes in plasmids for gene therapy [227].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [227]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782 · cited 1×
“To produce a recombinant protein, a way to avoid the antibiotic resistance marker is to integrate the gene of interest into bacterial chromosome [83].”
BackgroundMolecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092 · cited 1×
“It becomes clear that antibiotic-resistant bacteria are causing a global health crisis and that mechanisms behind acquisition of resistance are more and more documented [8].”
BackgroundHerrero, M., de Lorenzo, V, & Timmis, K. N. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.11.6557-6567.1990 · Cited by 1,586 · cited 1×
“[54]”
Gene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
Wiedenbeck, J., & Cohan, F. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00292.x · Cited by 663 · cited 1×
“More recently, acquisition of the virulence factors that distinguish Salmonella from Escherichia coli has been clearly shown as the result of horizontal gene transfer [13].”
BackgroundMini-F plasmid genes that couple host cell division to plasmid proliferation.
Ogura, T., & Hiraga, S. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4784 · Cited by 575 · cited 2×
“These authors also put in evidence that the combination SopA, SopB and SopC was not sufficient for a complete stabilization of mini-F plasmid, and thus identified the additional element ccd (control of cell death) region that seemed crucial to control cell division when copy number carrying ccd segment decreases [18].”
BackgroundPenicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae
DATTA, N., & KONTOMICHALOU, P. (1965) · Nature · doi:10.1038/208239a0 · Cited by 569 · cited 1×
“As early as in 1965, Datta and Kontomichalou [11] showed the widespread transfer of penicillin resistance across Enterobacteriaceae.”
BackgroundSummers, D. K., & Sherratt, D. J. (1984) · Cell · doi:10.1016/0092-8674(84)90060-6 · Cited by 452 · cited 1×
“Concerning plasmid maintenance, it has been shown that factors reducing multimerization of plasmid could increase plasmid stability [24].”
BackgroundNikol, S., Baumgartner, I., Van Belle, E., Diehm, C., Visoná, A., Capogrossi, M. C., Ferreira-Maldent, N., Gallino, A., Graham Wyatt, M., Dinesh Wijesinghe, L., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.33 · Cited by 333 · cited 1×
“First human phase I and II clinical trials using plasmid pCOR encoding fibroblast growth factor 1 have suggested an improvement of perfusion and an increase in amputation free survival in patients with critical limb ischemia [98].”
BackgroundA robust system for production of minicircle DNA vectors
Kay, M. A., He, C.-Y., & Chen, Z.-Y. (2010) · Nature Biotechnology · doi:10.1038/nbt.1708 · Cited by 329 · cited 1×
“Cre recombinase [87] or ΦC31 integrase [65,68].”
Research works printed but not linked: 1
- WHO (2005, January 24–28). Guidelines for assuring the quality of non clinical safety evaluation of DNA vaccines. Proceedings of the 56th Meeting of the WHO Expert Committee on Biological Standardization, Geneva, Switzerland.
Cited by
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
'Deadman' and 'Passcode' microbial kill switches for bacterial containment
Chan, C. T. Y., Lee, J. W., Cameron, D. E., Bashor, C. J., & Collins, J. J. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.1979 · Cited by 399
Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies
Cid, R., & Bolívar, J. (2021) · Biomolecules · doi:10.3390/biom11081072 · Cited by 176
Safety Aspects of Genetically Modified Lactic Acid Bacteria
Plavec, T. V., & Berlec, A. (2020) · Microorganisms · doi:10.3390/microorganisms8020297 · Cited by 156
“According to their mechanisms of action, these systems can be based on auxotrophic, nonantibiotic dominant and complementary markers, post-segregational killing, RNA interference, or de-repression of an essential gene or minicircle [88].”
BackgroundDNA Vaccines: Their Formulations, Engineering and Delivery
Kozak, M., & Hu, J. (2024) · Vaccines · doi:10.3390/vaccines12010071 · Cited by 115
“This has led to a concern about antibiotic resistance as a possible adverse effect of DNA vaccination should the antibiotic resistance gene be integrated [203].”
Backgroundİncir, İ., & Kaplan, Ö. (2024) · Protein Expression and Purification · doi:10.1016/j.pep.2024.106463 · Cited by 109
Buck, T., & Wijnholds, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124197 · Cited by 92
E. coli strain engineering for the production of advanced biopharmaceutical products
Selas Castiñeiras, T., Williams, S. G., Hitchcock, A. G., & Smith, D. C. (2018) · FEMS Microbiology Letters · doi:10.1093/femsle/fny162 · Cited by 92
Optimized gene expression from bacterial chromosome by high-throughput integration and screening
Saleski, T. E., Chung, M. T., Carruthers, D. N., Khasbaatar, A., Kurabayashi, K., & Lin, X. N. (2021) · Science Advances · doi:10.1126/sciadv.abe1767 · Cited by 104
Legastelois, I., Buffin, S., Peubez, I., Mignon, C., Sodoyer, R., & Werle, B. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1260795 · Cited by 83
“coli systems are continuously revisited, being easy to engineer and adapt to new constraints, such as antibiotic-free selection.(1,54) Some alternative gram-negative hosts have been investigated, including Pseudomonas fluorescens,(55) for which a complete toolbox is available, although its utility remains marginal com…”
BackgroundSelf-citationSynthetic auxotrophs for stable and tunable maintenance of plasmid copy number
Kang, C. W., Lim, H. G., Yang, J., Noh, M. H., Seo, S. W., & Jung, G. Y. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.05.020 · Cited by 75
Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics
Chen, Y., Liu, X., Guo, Y., Wang, J., Zhang, D., Yang, M. J., Shi, J., Tan, W., & Zheng, J. H. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.02.006 · Cited by 71
Genetically Engineered Microorganisms and Their Impact on Human Health
Mahdizade Ari, M., Dadgar, L., Elahi, Z., Ghanavati, R., & Taheri, B. (2024) · International Journal of Clinical Practice · doi:10.1155/2024/6638269 · Cited by 67
“However, chromosomal integration of the expression cassette without antibiotic selection markers usually provides a safer and more stable method of engineering [288, 289].”
MethodSandoz, K. M., Beare, P. A., Cockrell, D. C., & Heinzen, R. A. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.00261-16 · Cited by 76
Establishment of a yeast-based VLP platform for antigen presentation
Wetzel, D., Rolf, T., Suckow, M., Kranz, A., Barbian, A., Chan, J.-A., Leitsch, J., Weniger, M., Jenzelewski, V., Kouskousis, B. P., et al. (2018) · Microbial Cell Factories · doi:10.1186/s12934-018-0868-0 · Cited by 56
Addressing the safety of new food sources and production systems
Tan, Y. Q., Ong, H. C., Yong, A. M. H., Fattori, V., & Mukherjee, K. (2024) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.13341 · Cited by 61
“…may be used, such as precision fermentation and cell-based food production, industry and researchers may consider developing antibiotic-free selection methods to circumvent public health and environmental safety concerns during safety assessment and regulatory evaluation (Mignon et al., 2015).”
Wang, Y., Wang, D., Wang, X., Tao, H., Feng, E., Zhu, L., Pan, C., Wang, B., Liu, C., Liu, X., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01932 · Cited by 43
Reconsidering plasmid maintenance factors for computational plasmid design
Yano, H., Shintani, M., Tomita, M., Suzuki, H., & Oshima, T. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.12.001 · Cited by 43
“Mainly for biosafety reasons, various antibiotic marker-free selection approaches have been developed [3,71,72].”
BackgroundHuang, C., Guo, L., Wang, J., Wang, N., & Huo, Y. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10819-1 · Cited by 41
“In metabolic engineering, plasmid maintenance requires continuous antibiotic use, which has led to biosafety issues and elevated industrial cost [4].”
BackgroundCRISPR/Cas9 gene editing therapies for cystic fibrosis
Graham, C., & Hart, S. L. (2021) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1869208 · Cited by 43
Cheng, Z., Wu, J., Liu, J., Min, D., Liu, D., Li, W., & Yu, H. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac554 · Cited by 38
Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors
Williams, J. A., & Paez, P. A. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.04.003 · Cited by 39
Integration of Salmonella into Combination Cancer Therapy
Al-Saafeen, B. H., Fernández-Cabezudo, M. J., & al-Ramadi, B. K. (2021) · Cancers · doi:10.3390/cancers13133228 · Cited by 40
“Live genetically engineered bacteria that carry antibiotic resistance genes or mobile genetic elements are not suitable for clinical use since these recombinant elements can mediate horizontal gene transfer [185].”
BackgroundPierce, K. M., Miklavcic, W. R., Cook, K. P., Hennen, M. S., Bayles, K. W., Hollingsworth, M. A., Brooks, A. E., Pullan, J. E., & Dailey, K. M. (2021) · Nanomaterials · doi:10.3390/nano11113018 · Cited by 31
Biosynthesis of Lacto-N-fucopentaose I in Escherichia coli by metabolic pathway rational design
Hu, M., Li, M., Li, C., & Zhang, T. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120017 · Cited by 30
Campos, G. M., Américo, M. F., Freitas, A. D. S., Barroso, F. A. L., Dutra, J. D. C. F., Quaresma, L. S., Cordeiro, B. F., Laguna, J. G., de Jesus, L. C. L., Fontes, A. M., et al. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10041-1 · Cited by 30
“To overcome these concerns, the use of food-grade systems is an alternative strategy that can be based on auxotrophy, complementary markers, or the development of biocontainment strategies [8, 142].”
Engineering Escherichia coli for l ‐homoserine production
Sun, B., Wang, F., Zhao, J. H., Tao, X., Liu, M., & Wei, D. (2022) · Journal of Basic Microbiology · doi:10.1002/jobm.202200488 · Cited by 25
Becerra-Báez, E. I., Meza-Toledo, S. E., Muñoz-López, P., Flores-Martínez, L. F., Fraga-Pérez, K., Magaño-Bocanegra, K. J., Juárez-Hernández, U., Mateos-Chávez, A. A., & Luría-Pérez, R. (2022) · Cancers · doi:10.3390/cancers14174224 · Cited by 24
Wetzel, D., Barbian, A., Jenzelewski, V., Schembecker, G., Merz, J., & Piontek, M. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.10.008 · Cited by 23
Birštonas, L., Dallemulle, A., López‐Berges, M. S., Jacobsen, I. D., Offterdinger, M., Abt, B., Straßburger, M., Bauer, I., Schmidt, O., Sarg, B., et al. (2020) · mBio · doi:10.1128/mbio.00230-20 · Cited by 25
Petrus, M. L. C., Kiefer, L. A., Puri, P., Heemskerk, E., Seaman, M. S., Barouch, D. H., Arias, S., van Wezel, G. P., & Havenga, M. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10145-1 · Cited by 21
Engineered fluoride sensitivity enables biocontainment and selection of genetically-modified yeasts
Yoo, J. I., Seppälä, S., & O’Malley, M. (2020) · Nature Communications · doi:10.1038/s41467-020-19271-1 · Cited by 22
Mouhoub, E., Domenech, P., Ndao, M., & Reed, M. B. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.757858 · Cited by 22
Budge, J. D., Roobol, J., Singh, G., Mozzanino, T., Knight, T. J., Povey, J., Dean, A., Turner, S. J., Jaques, C., Young, R. J., et al. (2021) · Metabolic Engineering Communications · doi:10.1016/j.mec.2021.e00179 · Cited by 20
Kamenšek, U., Tešić, N., Serša, G., & Čemažar, M. (2018) · Cancers · doi:10.3390/cancers10030060 · Cited by 17
“Namely, according to the safety recommendation of the European Medicines Agency (EMA) [7], antibiotics should be avoided during production of plasmids for human use to circumvent possible allergic reactions in patients and the spread of antibiotic resistance traits to environmental and commensal microbes [8].”
BackgroundZhang, R., Yang, Y., Wang, J., Lin, Y., & Yan, Y. (2019) · Metabolic Engineering · doi:10.1016/j.ymben.2019.06.011 · Cited by 14
Sathesh‐Prabu, C., Tiwari, R., & Lee, S. K. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.960907 · Cited by 14
“, 2021) or creating antibioticfree plasmid maintenance systems (Mignon et al., 2015; Kang C. W. et al., 2018).”
BackgroundMethodFilluelo, O., Ferrando, J., & Picart, P. (2023) · AMB Express · doi:10.1186/s13568-023-01542-x · Cited by 12
Kamenšek, U., Tešić, N., Serša, G., Kos, Š., & Čemažar, M. (2016) · Plasmid · doi:10.1016/j.plasmid.2016.11.004 · Cited by 12
Kim, S. K., Kim, H., Woo, S. G., Kim, T. H., Rha, E., Kwon, K. K., Lee, H., Lee, S., & Lee, D. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1104 · Cited by 11
Inducible Selectable Marker Genes to Improve Aspergillus fumigatus Genetic Manipulation
Baldin, C., Kühbacher, A., Merschak, P., Sastré-Velásquez, L. E., Abt, B., Dietl, A., Haas, H., & Gsaller, F. (2021) · Journal of Fungi · doi:10.3390/jof7070506 · Cited by 10
Enabling HEK293 cells for antibiotic-free media bioprocessing through CRISPR/Cas9 gene editing
Román, R., Miret, J., Roura, A., Casablancas, A., Lecina, M., & Cairó, J. J. (2019) · Biochemical Engineering Journal · doi:10.1016/j.bej.2019.107299 · Cited by 9
Endogenous 2μ Plasmid Editing for Pathway Engineering in Saccharomyces cerevisiae
Zeng, B., Yao, M., Xiao, W., Luo, Y., Wāng, Y., & Yuan, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.631462 · Cited by 9
“For the high transformation efficiency and easy manipulation, plasmids have been developed as important tools and were widely applied in many kinds of organisms (Mignon et al., 2015; Lian et al., 2016).”
MethodAntibiotic-Free Nanoplasmids as Promising Alternatives for Conventional DNA Vectors
Seyed, N., Zahedifard, F., Habibzadeh, S., Yousefi, R., Lajevardi, M. S., Gholami, E., & Rafati, S. (2022) · Vaccines · doi:10.3390/vaccines10101710 · Cited by 9
Terrinoni, M., Nordqvist, S. L., Källgård, S., Holmgren, J. R., & Lebens, M. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.02143-17 · Cited by 9
Uthailak, N., Mahamad, P., Chittavanich, P., Yanarojana, S., Wijagkanalan, W., Pétré, J., & Panbangred, W. (2017) · Molecular Biotechnology · doi:10.1007/s12033-017-0001-3 · Cited by 8
Pasotti, L., Marchi, D. D., Casanova, M., Chiacchiera, A. F., Angelis, M. G. C. D., Calvio, C., & Magni, P. (2023) · Biotechnology for Biofuels and Bioproducts · doi:10.1186/s13068-023-02298-z · Cited by 9
Tratar, U. L., Jesenko, T., Omerzel, M., Seliškar, A., Stupan, U., Djokić, M., Sredenšek, J., Trotovšek, B., Serša, G., & Čemažar, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063151 · Cited by 7
“The latter is implemented in Europe by the European Medicines Agency (EMA) due to safety concerns regarding the use of antibiotics during the production of plasmids [23,24].”
BackgroundCao, Y., Wu, Y., Lv, X., Li, J., Liu, L., Du, G., Chen, J., & Liu, Y. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70162 · Cited by 6
“For the stability of plasmid expression systems, plasmid loss is now a major concern (Mignon et al. 2015; Zang, Yang, et al. 2019).”
Mmbando, G. S. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00609-7 · Cited by 6
Dièye, Y., Nguer, C. M., Thiam, F., Diouara, A. A. M., & Fall, C. (2022) · Antibiotics · doi:10.3390/antibiotics11121701 · Cited by 6
Long, J., Xiao, Z., Fang, Y., Fei, L., Nan, L., Song, Y. S., Ling, W., Sun, Y., & Xi, Y. (2016) · Process Biochemistry · doi:10.1016/j.procbio.2016.10.020 · Cited by 6
Eguia, F. A. P., Ramos, H. R., Kraschowetz, S., Omote, D., Ramos, C. R. R., Ho, P. L., Carvalho, E., & Gonçalves, V. M. (2018) · Plasmid · doi:10.1016/j.plasmid.2018.08.004 · Cited by 6
Kumar, S. (2019) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-01881-8_2 · Cited by 5
Kamenšek, U., Renčelj, A., Jesenko, T., Remic, T., Serša, G., & Čemažar, M. (2021) · Heliyon · doi:10.1016/j.heliyon.2022.e08879 · Cited by 6
“As an alternative to antibiotic selection, several antibiotic-free plasmid production techniques have been developed in the last decades [23, 24, 25].”
BackgroundHarnessing microbial heterogeneity for improved biosynthesis fueled by synthetic biology
Cao, Y., Li, J., Liu, L., Du, G., & Liu, Y. (2024) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2024.11.004 · Cited by 4
Considerations of Bacterial Robustness and Stability to Improve Bioprocess Design
Pijpstra, P., Guillouet, S., Heidinger, P., Kourist, R., & Gorret, N. (2026) · Fermentation · doi:10.3390/fermentation12010054 · Cited by 4
Fan, Y., Tang, Q., Sun, H., & Yu, H. (2022) · Environmental Microbiology · doi:10.1111/1462-2920.16181 · Cited by 5
Constructing Clinically Applicable Plasmids for Cancer Gene Therapy
Kamenšek, U., Tesic, N., Serša, G., & Čemažar, M. (2015) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-981-287-817-5_69 · Cited by 4
Pinyon, J. L., von Jonquières, G., Mow, S. L., Abed, A. A., Lai, K., Manoharan, M., Crawford, E. N., Xue, S. H., Smith‐Moore, S., Caproni, L. J., et al. (2024) · Advanced Science · doi:10.1002/advs.202406545 · Cited by 3
Pasini, M., Fernández‐Castané, A., Caminal, G., Overton, T. W., & Ferrer, P. (2022) · Journal of Industrial Microbiology & Biotechnology · doi:10.1093/jimb/kuac018 · Cited by 4
DNA Vaccine Technologies: Design and Delivery
Fando, A. A., Ilyichev, A. A., Litvinova, V. R., Борисовна, Р. Н., Карпенко, Л. И., & Рудометов, А. П. (2025) · Molecular Biology · doi:10.1134/s0026893324700675 · Cited by 3
“Free amino and hydroxyl groups have been used to create a wide range of chitosan derivatives with improved solubility based on its high affinity for functional proteins and self-assembly ability [43, 94, 95].”
Yuen, V. F. K., Yuan, D., Zhou, Y., Wang, H., Tan, D. Z. J., & Zhou, K. (2023) · Biochemical Engineering Journal · doi:10.1016/j.bej.2023.109007 · Cited by 2
Joseph-Munné, J., Maya-Hoyos, M., Saubi, N., Pérez‐Hoyos, S., Lopez, M. A. M., Baron, E., & Soto, C. Y. (2025) · Vaccines · doi:10.3390/vaccines13060606 · Cited by 3
Heller, R. F., Teissié, J., Rols, M., Gehl, J., Serša, G., Mir, L. M., Neal, R. E., Bhonsle, S. P., Davalos, R. V., Beebe, S. J., et al. (2016) · Springer eBooks · doi:10.1007/978-4-431-56095-1_5 · Cited by 2
Salerno, P., Leckenby, M. W., Humphrey, B., & Cranenburgh, R. M. (2022) · Synthetic Biology · doi:10.1093/synbio/ysac005 · Cited by 1
Cao, L., Na, D.-Y., Cheng, J., Zhao, L., Ye, Q., & Tan, W.-S. (2026) · Biotechnology and Bioengineering · doi:10.1002/bit.70185 · Cited by 1
“Among modern selection strategies, metabolic selection systems have surpassed antibiotic‐based methods, as they avoid bio-safety concerns, simplify downstream purification, and can be engineered to modulate cellular metabolism (Davies and Davies 2010; Mignon et al. 2015; Ryu et al. 2017).”
The TfoX revolution: a review of genetic engineering in Vibrio natriegens
Zhong, S., Tang, J., & Dai, Z. (2026) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2026.103506 · Cited by 1
Donassolo, R. A., Ferreira, M. R. A., Moreira, C., dos Santos, L. M., Griep, E., Moreira, G. M. S. G., Rodrigues, R. R., Moreira, Â. N., & Conceição, F. R. (2020) · Biotechnology Letters · doi:10.1007/s10529-020-02929-7 · Cited by 1
Gene Nanovector for Genome Therapy
Ma, D., & Xi, Z. (2023) · Springer eBooks · doi:10.1007/978-981-19-9776-1_60 · Cited by 1
Greco, E. D. (2017) · Dominican Scholar (Dominican University of California) · doi:10.33015/dominican.edu/2017.bio.06
Matsumura, I., & Chyong, D. I. (2019) · Protein Engineering Design and Selection · doi:10.1093/protein/gzaa007
Huang, C., Guo, L., Wang, J., Wang, N., & Huo, Y. (2020) · doi:10.21203/rs.2.22299/v1
Miyamoto, Y., Tsukamoto, Y., Maeda, Y., Tamura, T., Mukai, T., Ato, M., & Makino, M. (2021) · Tuberculosis · doi:10.1016/j.tube.2021.102105
Gene Nanovector for Genome Therapy
Ma, D., & Xi, Z. (2022) · Springer eBooks · doi:10.1007/978-981-16-1313-5_60-1 · Cited by 1
Arp2/3 mediated dynamic lamellipodia of the hPSC colony edges promote liposome-based DNA delivery
Surma, M. L., Anbarasu, K., & Das, A. (2024) · Stem Cells · doi:10.1093/stmcls/sxae033
Bäcker, L. E., Baert, F., Broux, K., Oome, D., Simoens, K., Waldherr, S., Bernaerts, K., & Aertsen, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.31.673379
Zhao, B., Zhang, B., Kang, Y., Liu, S., Jia, Z.-Y., Lu, C.-L., Cao, Y.-J., Xu, A., Lee, K.-S., Zhang, Z., et al. (2025) · Biotechnology progress (Print) · doi:10.1002/btpr.70091
Filluelo, O., Ferrando, J., & Picart, P. (2024) · Figshare · doi:10.6084/m9.figshare.26586000
Pasotti, L., Marchi, D. D., Casanova, M., Frusteri Chiacchiera, A., Angelis, M. G. C. D., Calvio, C., & Magni, P. (2024) · Figshare · doi:10.6084/m9.figshare.26579795
Cao, L., Shao, Y., Zhou, Y., Zhao, L., Zhou, Y., Ye, Q., & Tan, W.-S. (2026) · Biochemical engineering journal · doi:10.1016/j.bej.2026.110113
Yang, J., Chen, S. S., Idnani, E., Shannon, S. R., Luly, K. M., Fabilane, C. S., Wilson, D. S., Spangler, J. B., Tzeng, S. Y., & Green, J. J. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201708
“20 The FDA also recommends against the usage of antibiotic selection markers in gene therapy.”
Genetically Modified Microorganisms Being Released into Ecosystems
Abd-El-Haleem, D. A. M. (2026) · Wiley eBooks · doi:10.1002/9781119620303.ch14
Yuan, C., Liu, Y., He, G., Xu, T., Wang, P., Liu, J., Liu, S., & Shi, K. (2026) · Foods · doi:10.3390/foods15061025
“Antibiotic susceptibility is critical not only for consumer safety but also for preventing the horizontal transfer of resistance genes within the gastrointestinal environment [56].”
Flanagan, K. A., Cazeault, N. R., Li, H., Kass, E., Petersson, K., Ostroff, G. R., & Aroian, R. V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.24.720002
Cao, L., Zhao, L., Zhou, Y., Ye, Q., & Tan, W.-S. (2026) · Biotechnology Journal · doi:10.1002/biot.70265
“Metabolic selection systems represented by glutamine synthetase (GS) and dihydrofolate reductase (DHFR) have been widely adopted in the industry, avoiding gene expression interference, purification-related complexity, and safety risks associated with antibiotic-based systems [4, 5].”
Martínez, S. J. C., Quimbita, B. N. G., Pucha, S. C. G., & Naranjo, C. D. G. (2026) · Polo del Conocimiento · doi:10.23857/pc.v11i7.12199
Bakhsh, M., Kwon, J., Haq, I. U., Riaz, J., Kim, C. M., & Lee, J. H. (2026) · Biotechnology Advances · doi:10.1016/j.biotechadv.2026.109078
Metadata
- Authors
- Mignon, C., Sodoyer, R., & Werle, B.
- Affiliations
- BIOASTER (FR)
- Corresponding author
- Sodoyer, Régis
- ORCID
- Mignon, Charlotte
- Venue
- Pathogens
- Publisher
- MDPI AG
- Published
- 2015-04-03
- Volume
- 4
- Issue
- 2
- Pages
- 157-181
- ISSN
- 2076-0817 (ISSN-L)
- PMC
- PMC4493468
- OpenAlex
- W2057140623
- Cited by
- 87
- References
- 110
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 9 · 2023: 6 · 2022: 14 · 2021: 12 · 2020: 7 · 2019: 7 · 2018: 7 · 2017: 3 · 2016: 5 · 2015: 2
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
- Keywords
- antibiotic-free selection, biopharmaceutical manufacturing, DNA vaccine, gene therapy products, delivery vehicles, molecular engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.